Literature DB >> 25049074

Differential dopamine receptor subtype regulation of adenylyl cyclases in lipid rafts in human embryonic kidney and renal proximal tubule cells.

Peiying Yu1, Min Sun2, Van Anthony M Villar1, Yanrong Zhang1, Edward J Weinman1, Robin A Felder3, Pedro A Jose4.   

Abstract

Dopamine D1-like receptors (D1R and D5R) stimulate adenylyl cyclase (AC) activity, whereas the D2-like receptors (D2, D3 and D4) inhibit AC activity. D1R, but not the D5R, has been reported to regulate AC activity in lipid rafts (LRs). We tested the hypothesis that D1R and D5R differentially regulate AC activity in LRs using human embryonic kidney (HEK) 293 cells heterologously expressing human D1 or D5 receptor (HEK-hD1R or HEK-hD5R) and human renal proximal tubule (hRPT) cells that endogenously express D1R and D5R. Of the AC isoforms expressed in HEK and hRPT cells (AC3, AC5, AC6, AC7, and AC9), AC5/6 was distributed to a greater extent in LRs than non-LRs in HEK-hD1R (84.5±2.3% of total), HEK-hD5R (68.9±3.1% of total), and hRPT cells (66.6 ± 2.2% of total) (P<0.05, n=4/group). In HEK-hD1R cells, the D1-like receptor agonist fenoldopam (1 μM/15 min) increased AC5/6 protein (+17.2 ± 3.9% of control) in LRs but decreased it in non-LRs (-47.3±5.3% of control) (P<0.05, vs. control, n=4/group). By contrast, in HEK-hD5R cells, fenoldopam increased AC5/6 protein in non-LRs (+67.1 ± 5.3% of control, P<0.006, vs. control, n=4) but had no effect in LRs. In hRPT cells, fenoldopam increased AC5/6 in LRs but had little effect in non-LRs. Disruption of LRs with methyl-β-cyclodextrin decreased basal AC activity in HEK-D1R (-94.5 ± 2.0% of control) and HEK-D5R cells (-87.1 ± 4.6% of control) but increased it in hRPT cells (6.8±0.5-fold). AC6 activity was stimulated to a greater extent by D1R than D5R, in agreement with the greater colocalization of AC5/6 with D1R than D5R in LRs. We conclude that LRs are essential not only for the proper membrane distribution and maintenance of AC5/6 activity but also for the regulation of D1R- and D5R-mediated AC signaling.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adenylyl cyclase; Dopamine receptor; Lipid rafts; Signal transduction

Mesh:

Substances:

Year:  2014        PMID: 25049074      PMCID: PMC4166567          DOI: 10.1016/j.cellsig.2014.07.003

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  46 in total

Review 1.  Higher-order organization and regulation of adenylyl cyclases.

Authors:  Dermot M F Cooper; Andrew J Crossthwaite
Journal:  Trends Pharmacol Sci       Date:  2006-07-03       Impact factor: 14.819

2.  Probing the activation-promoted structural rearrangements in preassembled receptor-G protein complexes.

Authors:  Céline Galés; Joost J J Van Durm; Stéphane Schaak; Stéphanie Pontier; Yann Percherancier; Martin Audet; Hervé Paris; Michel Bouvier
Journal:  Nat Struct Mol Biol       Date:  2006-08-13       Impact factor: 15.369

3.  Differential D1 and D5 receptor regulation and degradation of the angiotensin type 1 receptor.

Authors:  John J Gildea; Xiaoli Wang; Pedro A Jose; Robin A Felder
Journal:  Hypertension       Date:  2008-01-02       Impact factor: 10.190

4.  Compartmentation of cyclic adenosine 3',5'-monophosphate signaling in caveolae.

Authors:  C Schwencke; M Yamamoto; S Okumura; Y Toya; S J Kim; Y Ishikawa
Journal:  Mol Endocrinol       Date:  1999-07

5.  D5 dopamine receptor regulation of reactive oxygen species production, NADPH oxidase, and blood pressure.

Authors:  Zhiwei Yang; Laureano D Asico; Peiying Yu; Zheng Wang; John E Jones; Crisanto S Escano; Xiaoyan Wang; Mark T Quinn; David R Sibley; Guillermo G Romero; Robin A Felder; Pedro A Jose
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2006-01       Impact factor: 3.619

6.  D1 dopamine receptor signaling involves caveolin-2 in HEK-293 cells.

Authors:  Peiying Yu; Zhiwei Yang; John E Jones; Zheng Wang; Shaun A Owens; Susette C Mueller; Robin A Felder; Pedro A Jose
Journal:  Kidney Int       Date:  2004-12       Impact factor: 10.612

7.  Introduction of bisecting GlcNAc in N-glycans of adenylyl cyclase III enhances its activity.

Authors:  Wei Li; Motoko Takahashi; Yukinao Shibukawa; Shunichi Yokoe; Jianguo Gu; Eiji Miyoshi; Koichi Honke; Yoshitaka Ikeda; Naoyuki Taniguchi
Journal:  Glycobiology       Date:  2007-02-26       Impact factor: 4.313

Review 8.  Organization and Ca2+ regulation of adenylyl cyclases in cAMP microdomains.

Authors:  Debbie Willoughby; Dermot M F Cooper
Journal:  Physiol Rev       Date:  2007-07       Impact factor: 37.312

9.  Lipid rafts keep NADPH oxidase in the inactive state in human renal proximal tubule cells.

Authors:  Weixing Han; Hewang Li; Van Anthony M Villar; Annabelle M Pascua; Mustafa I Dajani; Xiaoyang Wang; Aruna Natarajan; Mark T Quinn; Robin A Felder; Pedro A Jose; Peiying Yu
Journal:  Hypertension       Date:  2008-01-14       Impact factor: 10.190

10.  Regulation of D1 dopamine receptor trafficking and signaling by caveolin-1.

Authors:  Michael M C Kong; Ahmed Hasbi; Michael Mattocks; Theresa Fan; Brian F O'Dowd; Susan R George
Journal:  Mol Pharmacol       Date:  2007-08-15       Impact factor: 4.436

View more
  16 in total

1.  A Novel CRISPR/Cas9-Based Cellular Model to Explore Adenylyl Cyclase and cAMP Signaling.

Authors:  Monica Soto-Velasquez; Michael P Hayes; Aktan Alpsoy; Emily C Dykhuizen; Val J Watts
Journal:  Mol Pharmacol       Date:  2018-06-27       Impact factor: 4.436

Review 2.  Primary cilia: Cell and molecular mechanosensors directing whole tissue function.

Authors:  Milos Spasic; Christopher R Jacobs
Journal:  Semin Cell Dev Biol       Date:  2017-08-24       Impact factor: 7.727

3.  Lengthening primary cilia enhances cellular mechanosensitivity.

Authors:  M Spasic; C R Jacobs
Journal:  Eur Cell Mater       Date:  2017-02-20       Impact factor: 3.942

4.  Lipid rafts are required for effective renal D1 dopamine receptor function.

Authors:  Andrew C Tiu; Jian Yang; Laureano D Asico; Prasad Konkalmatt; Xiaoxu Zheng; Santiago Cuevas; Xiaoyan Wang; Hewang Lee; Momina Mazhar; Robin A Felder; Pedro A Jose; Van Anthony M Villar
Journal:  FASEB J       Date:  2020-04-07       Impact factor: 5.191

Review 5.  cAMP Signaling Compartmentation: Adenylyl Cyclases as Anchors of Dynamic Signaling Complexes.

Authors:  Timothy B Johnstone; Shailesh R Agarwal; Robert D Harvey; Rennolds S Ostrom
Journal:  Mol Pharmacol       Date:  2017-12-07       Impact factor: 4.436

6.  The Dopamine D1 Receptor and Angiotensin II Type-2 Receptor are Required for Inhibition of Sodium Transport Through a Protein Phosphatase 2A Pathway.

Authors:  John J Gildea; Peng Xu; Brandon A Kemp; Robert M Carey; Pedro A Jose; Robin A Felder
Journal:  Hypertension       Date:  2019-06       Impact factor: 10.190

Review 7.  Regulation of monoamine transporters and receptors by lipid microdomains: implications for depression.

Authors:  Joanne J Liu; Adrienne Hezghia; Saame Raza Shaikh; Joshua F Cenido; Ruth E Stark; J John Mann; M Elizabeth Sublette
Journal:  Neuropsychopharmacology       Date:  2018-06-28       Impact factor: 7.853

Review 8.  Connectome and molecular pharmacological differences in the dopaminergic system in restless legs syndrome (RLS): plastic changes and neuroadaptations that may contribute to augmentation.

Authors:  Christopher J Earley; George R Uhl; Stefan Clemens; Sergi Ferré
Journal:  Sleep Med       Date:  2016-06-27       Impact factor: 3.492

Review 9.  International Union of Basic and Clinical Pharmacology. CI. Structures and Small Molecule Modulators of Mammalian Adenylyl Cyclases.

Authors:  Carmen W Dessauer; Val J Watts; Rennolds S Ostrom; Marco Conti; Stefan Dove; Roland Seifert
Journal:  Pharmacol Rev       Date:  2017-04       Impact factor: 25.468

Review 10.  Renal Dopamine Receptors and Oxidative Stress: Role in Hypertension.

Authors:  Jian Yang; Van Anthony M Villar; Pedro A Jose; Chunyu Zeng
Journal:  Antioxid Redox Signal       Date:  2020-05-29       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.